Impact of targeted testing for latent tuberculosis infection using commercially available diagnostics

Clinical Infectious Diseases

Volumn 53, Issue 3, 2011, Pages 234-244

  Mancuso, James D ^a,b   Tribble, David ^b   Mazurek, Gerald H ^d   Li, Yuanzhang ^a   Olsen, Cara ^b   Aronson, Naomi E ^b   Geiter, Lawrence ^c   Goodwin, Donald ^e   Keep, Lisa W ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c Otsuka Pharmaceuticals   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e US Air Force School of Aerospace Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; INFECTION RISK; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; LATENT TUBERCULOSIS; LOGISTIC REGRESSION ANALYSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; RISK FACTOR QUESTIONNAIRE; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; TRAINING; TUBERCULIN TEST; UNITED STATES;

ADOLESCENT; ADULT; CLINICAL LABORATORY TECHNIQUES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOASSAY; LATENT TUBERCULOSIS; MALE; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SOUTH CAROLINA; YOUNG ADULT;

EID: 79960811166     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir321     Document Type: Article

References (29)

1. Centers for Disease Control and Population. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000; 49:1-51.
2. Geiter L, ed. Ending neglect: the elimination of tuberculosis in the United States. Washington, DC: National Academy of Sciences, 2000.
3. Rose DN, Schechter CB, Adler JJ. Interpretation of the tuberculin skin test. J Gen Intern Med 1995; 10:635-42.
4. Jensen PA, Lambert LA, Iademarco MF, Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in healthcare settings, 2005. MMWR Recomm Rep 2005; 54:1-141.
5. Bailey WC, Gerald LB, Kimerling ME, et al. Predictive model to identify positive tuberculosis skin test results during contact investigations. JAMA 2002; 287:996-1002. (Pubitemid 34252057)
6. Aissa K, Madhi F, Ronsin N, et al. Evaluation of a model for efficient screening of tuberculosis contact subjects. Am J Respir Crit Care Med 2008; 177:1041-7. (Pubitemid 351717600)
7. Ozuah PO, Ozuah TP, Stein RE, Burton W, Mulvihill M. Evaluation of a risk assessment questionnaire used to target tuberculin skin testing in children. JAMA 2001; 285:451-3. (Pubitemid 32098029)
8. Froehlich H, Ackerson LM, Morozumi PA. Targeted testing of children for tuberculosis: validation of a risk assessment questionnaire. Pediatrics 2001; 107:E54.
9. Koppaka VR, Harvey E, Mertz B, Johnson BA. Risk factors associated with tuberculin skin test positivity among university students and the use of such factors in the development of a targeted screening program. Clin Infect Dis 2003; 36:599-607. (Pubitemid 36259565)
10. Edwards LB, Palmer CE. Part II. tuberculous infection. In Lowell AM, ed. Tuberculosis. Cambridge, Massachusetts: Harvard University Press, 1969; 123-204.
11. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149:177-84.
12. Bennett DE, Courval JM, Onorato I, et al. Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000. Am J Respir Crit Care Med 2008; 177:348-55. (Pubitemid 351198380)
13. Mazurek GH, Zajdowicz MJ, Hankinson AL, et al. Detection of Mycobacterium uberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays. Clin Infect Dis 2007; 45:826-36. (Pubitemid 47580373)
14. World Health Organization. Global tuberculosis database. March 24 2009. Available at: en/. Accessed 27 December 2009.
15. Cellestis. Quantiferon-TB gold (in tube method) package insert. Valencia, CA: Cellestis, Inc., 2007.
16. Oxford Immunotec. T-SPOT.TB package insert. Marlborough, MA: Oxford Immunotec Limited, 2008.
17. Centers for Disease Control and Population. Mantoux tuberculin skin test: facilitator guide. 2008. Available at: Mantoux/images/Mantoux.pdf. Accessed 4 November 2008.
18. Centers for Disease Control and Population. National health and nutrition examination survey: tuberculosis skin test procedures manual. 2000. Available at: .
19. Cassell DL. Don't be loopy: re-sampling and simulation the SAS(R) way. SAS Global Form 2007. Cary, NC, 2007.
20. Efron B, Tibshirani R. An introduction to the bootstrap. Boca Raton, FL: Chapman and Hall/CRC, 1998.
21. Scholten JN, Fujiwara PI, Frieden TR. Prevalence and factors associated with tuberculosis infection among new school entrants, New York City, 1991-1993. Int J Tuberc Lung Dis 1999; 3:31-41. (Pubitemid 29136558)
22. Gounder CR, Driver CR, Scholten JN, Shen H, Munsiff SS. Tuberculin testing and risk of tuberculosis infection among New York City schoolchildren. Pediatrics 2003; 111:e309-15.
23. Lobato MN, Hopewell PC. Mycobacterium tuberculosis infection after travel to or contact with visitors from countries with a high prevalence of tuberculosis. Am J Respir Crit Care Med 1998; 158: 1871-5.
24. Mancuso JD, Tobler SK, Keep LW. Pseudoepidemics of tuberculin skin test conversions in the U.S. Army after recent deployments. Am J Respir Crit Care Med 2008; 177:1285-9. (Pubitemid 351860939)
25. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010; 59:1-25.
26. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993; 17:968-75. (Pubitemid 23358739)
27. Rust P, Thomas J. A method for estimating the prevalence of tuberculosis infection. Am J Epidemiol 1975; 101:311-22.
28. Cobelens FG, van Deutekom H, Draayer-Jansen IW, et al. Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity. Lancet 2000; 356:461-5. (Pubitemid 30496817)
29. US Army. Supplemental guidance for the Army Latent Tuberculosis Infection (LTBI) Surveillance and Control Program. Office of the Surgeon General, 2008. (25 September 2008).